TRAVASOL 3.5% W/ ELECTROLYTES Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Travasol 3.5% W/ Electrolytes, and when can generic versions of Travasol 3.5% W/ Electrolytes launch?
Travasol 3.5% W/ Electrolytes is a drug marketed by Baxter Hlthcare and is included in two NDAs.
The generic ingredient in TRAVASOL 3.5% W/ ELECTROLYTES is amino acids; magnesium chloride; potassium phosphate, dibasic; sodium acetate; sodium chloride. There are three hundred and fifty drug master file entries for this compound. Additional details are available on the amino acids; magnesium chloride; potassium phosphate, dibasic; sodium acetate; sodium chloride profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for TRAVASOL 3.5% W/ ELECTROLYTES?
- What are the global sales for TRAVASOL 3.5% W/ ELECTROLYTES?
- What is Average Wholesale Price for TRAVASOL 3.5% W/ ELECTROLYTES?
Summary for TRAVASOL 3.5% W/ ELECTROLYTES
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 2 |
| DailyMed Link: | TRAVASOL 3.5% W/ ELECTROLYTES at DailyMed |
US Patents and Regulatory Information for TRAVASOL 3.5% W/ ELECTROLYTES
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Baxter Hlthcare | TRAVASOL 3.5% SULFITE FREE W/ ELECTROLYTES IN PLASTIC CONTAINER | amino acids; magnesium chloride; potassium phosphate, dibasic; sodium acetate; sodium chloride | INJECTABLE;INJECTION | 020177-001 | Oct 23, 1995 | DISCN | No | No | ⤷ Subscribe | ⤷ Subscribe | ⤷ Subscribe | ||||
| Baxter Hlthcare | TRAVASOL 3.5% W/ ELECTROLYTES | amino acids; magnesium chloride; potassium phosphate, dibasic; sodium acetate; sodium chloride | INJECTABLE;INJECTION | 017493-003 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Subscribe | ⤷ Subscribe | ⤷ Subscribe | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
